No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Monday, October 27, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Astrazeneca sets up Tel Aviv center to study Israeli health data

by TheAdviserMagazine
6 months ago
in Business
Reading Time: 2 mins read
A A
Astrazeneca sets up Tel Aviv center to study Israeli health data
Share on FacebookShare on TwitterShare on LInkedIn



How much are the Israeli digital medical data files of each patient, gathered over decades, worth to the world’s leading pharmaceutical companies? Opinions on this subject are divided and change from time to time. Shortly before and during the Covid pandemic, the prevailing consensus was that databases gave the Israeli biomedical sector a huge advantage and were a factor that would attract the activities of leading companies here. These expectations were only partially realized, but this week an agreement was signed that nevertheless gives hope for leveraging the country’s wealth of knowledge.

AstraZeneca has launched the Beam – Illuminating Healthcare Through Data Center with the School of Public Health and School of Medicine at Tel Aviv University, and the Leumit and Meuhedet health funds. This is the second research center of its kind established by the company in the world.

The center will use data collected from health insurance companies and anonymized, and will allow AstraZeneca to use the data to better understand disease mechanisms, new treatment methods and how to improve patient’s quality of life. University researchers will help the company study the databases.

In recent years, the ability to analyze real-world data has improved due to AI tools and computational power. Studying real-world data is now considered an important complementary tool to clinical trials, and it makes it possible to understand the effectiveness of drugs in patients with several diseases or in elderly patients who were not included in clinical trials; to test combinations of drugs or test treatment methods against each other, and not just against a control group receiving a placebo treatment. It is also possible to identify rare side effects, distinguish between patients who are expected to respond to treatment or not, or to personalize treatment. The databases can also be used to understand the economic value of a treatment in a particular group of patients.

The center will be headed by Tel Aviv University’s Prof. Gabriel Hudik. He says this is an innovative center in several aspects: “Firstly, in a triangle of industry, academia and health services that combine forces to promote research and medical services. Secondly, investment in improving the excellent databases of the health funds in order to enable higher-level research, and thirdly, the use of federated learning that will enable research collaboration between organizations without sharing data. This is to ensure complete data privacy. This is a significant step forward in the world of data science in the health sector.”

AstraZeneca Israel CEO Ohad Goldberg added at the launch of the project: “Through collaborations between academia, industry and health funds, we will be able to promote in-depth research and data-based learning, better understand the needs of patients today, and develop medical solutions that will benefit them in the future.”

Published by Globes, Israel business news – en.globes.co.il – on April 28, 2025.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2025.




Source link

Tags: AstraZenecaAvivCenterdataHealthIsraeliSetsStudyTel
ShareTweetShare
Previous Post

Here’s Why SouthernSun SMID Cap Strategy Maintains Its Confidence in Broadridge Financial Solutions (BR)

Next Post

How US Businesses Must Think Beyond Survival

Related Posts

edit post
Nobel prize winner says Venezuela has a ‘unique’ .7 trillion opportunity to privatize its companies and reverse socialist ‘disaster’

Nobel prize winner says Venezuela has a ‘unique’ $1.7 trillion opportunity to privatize its companies and reverse socialist ‘disaster’

by TheAdviserMagazine
October 27, 2025
0

Weeks after winning the 2025 Nobel Peace Prize for her decades-long fight to restore democracy to Venezuela, opposition leader María...

edit post
Medtronic Jerusalem unit to lay off 60 employees

Medtronic Jerusalem unit to lay off 60 employees

by TheAdviserMagazine
October 27, 2025
0

Medical device giant Medtronic, which has 1,000 employees at eight development centers in Israel, is set to lay off...

edit post
Wright Flood to acquire Poulton Associates

Wright Flood to acquire Poulton Associates

by TheAdviserMagazine
October 27, 2025
0

Wright National Flood Insurance Company (Wright Flood), through its affiliate Wright National Flood Insurance Services, is set to acquire the...

edit post
Adani Energy Q2 Results: Cons profit falls 21% YoY to Rs 534 crore, revenue rises 7%

Adani Energy Q2 Results: Cons profit falls 21% YoY to Rs 534 crore, revenue rises 7%

by TheAdviserMagazine
October 27, 2025
0

Adani Energy Solutions on Monday reported 21% decline in its consolidated net profit at Rs 534 crore for the quarter...

edit post
Trump: U.S.-China trade deal, TikTok sale likely this week

Trump: U.S.-China trade deal, TikTok sale likely this week

by TheAdviserMagazine
October 27, 2025
0

Oct. 27, 2025 5:38 AM ETiShares China Large-Cap ETF (FXI), YINN, YANG, MCHI, ASHR, PGJ, BDNCE Stock, REMX, SOYB, SETMBy:...

edit post
CDSL, Tata Consumer among top buys as markets regain uptrend: Rajesh Bhosale

CDSL, Tata Consumer among top buys as markets regain uptrend: Rajesh Bhosale

by TheAdviserMagazine
October 27, 2025
0

After a brief bout of profit booking, the bulls seem to have regained control of Dalal Street, with both Nifty...

Next Post
edit post
How US Businesses Must Think Beyond Survival

How US Businesses Must Think Beyond Survival

edit post
Sebi comes out with timelines for brokers to collect margins

Sebi comes out with timelines for brokers to collect margins

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
9 Things Retirees Should Stop Buying, According to Financial Experts

9 Things Retirees Should Stop Buying, According to Financial Experts

0
edit post
A Mind-Blowing Way of Looking at Math (with David Bessis)

A Mind-Blowing Way of Looking at Math (with David Bessis)

0
edit post
Adani Energy Q2 Results: Cons profit falls 21% YoY to Rs 534 crore, revenue rises 7%

Adani Energy Q2 Results: Cons profit falls 21% YoY to Rs 534 crore, revenue rises 7%

0
edit post
Shiba Inu Hides A 2,000% End-Cycle Breakout, Analyst Predicts

Shiba Inu Hides A 2,000% End-Cycle Breakout, Analyst Predicts

0
edit post
How Wage Increases Compare to Inflation, According to Workers

How Wage Increases Compare to Inflation, According to Workers

0
edit post
Alphabet: Chart-Setup deutet auf dynamische Trendfortsetzung hin!

Alphabet: Chart-Setup deutet auf dynamische Trendfortsetzung hin!

0
edit post
9 Things Retirees Should Stop Buying, According to Financial Experts

9 Things Retirees Should Stop Buying, According to Financial Experts

October 27, 2025
edit post
Shiba Inu Hides A 2,000% End-Cycle Breakout, Analyst Predicts

Shiba Inu Hides A 2,000% End-Cycle Breakout, Analyst Predicts

October 27, 2025
edit post
Nobel prize winner says Venezuela has a ‘unique’ .7 trillion opportunity to privatize its companies and reverse socialist ‘disaster’

Nobel prize winner says Venezuela has a ‘unique’ $1.7 trillion opportunity to privatize its companies and reverse socialist ‘disaster’

October 27, 2025
edit post
Bessent lists Fed chair finalists, Trump says decision by end of year

Bessent lists Fed chair finalists, Trump says decision by end of year

October 27, 2025
edit post
How Wage Increases Compare to Inflation, According to Workers

How Wage Increases Compare to Inflation, According to Workers

October 27, 2025
edit post
Medtronic Jerusalem unit to lay off 60 employees

Medtronic Jerusalem unit to lay off 60 employees

October 27, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • 9 Things Retirees Should Stop Buying, According to Financial Experts
  • Shiba Inu Hides A 2,000% End-Cycle Breakout, Analyst Predicts
  • Nobel prize winner says Venezuela has a ‘unique’ $1.7 trillion opportunity to privatize its companies and reverse socialist ‘disaster’
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.